Celldex Therapeutics has announced promising results from its Phase 2 clinical trial of barzolvolimab, a treatment for chronic spontaneous urticaria (CSU), demonstrating significant improvements in ...

Hereditary angioedema (HAE) is a rare genetic condition that causes swelling under the skin and lining of your gut and lungs. “Angio” means it affects your blood vessels. “Edema” means swelling. So ...

Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.

RAPIDe-3 met the primary and all 11 secondary efficacy endpoints with high statistical significance with deucrictibant achieving onset of symptom ...

Hereditary angioedema (HAE) is a genetic disorder that causes episodes of extreme swelling (angioedema), commonly in the face, hands, feet, digestive tract, or upper airways. Symptoms may begin before ...

Please provide your email address to receive an email when new articles are posted on . Patients with chronic spontaneous urticaria demonstrated improved outcomes related to idiopathic angioedema ...

The goal of acute treatment of an hereditary angioedema (HAE) attack is to reduce its duration and severity and thus limit its impact on the patient’s functional ability and prevent a potentially ...

Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with dermatomyositis usually require prompt treatment with intense ...

Before 2008, treatment options for hereditary angioedema were limited. Now there are eight FDA-approved medications and even more promising therapies on the horizon. Hereditary angioedema (HAE) is a ...